Abstract

Introduction. Cannabinoid Hyperemesis Syndrome (CHS) is a rare condition that includes cyclic severe vomiting in subjects who have been consuming large doses of cannabis for several years. One of the major diagnostic criteria is the alleviation of symptoms by hot showers. The syndrome was first described in 2004 and is so far neither completely understood nor well known. The latter leads to continued morbidity in concerned subjects and unnecessary expenses for futile investigations. Standard treatments of vomiting as 5-HT3 or D2-receptor antagonists have been shown to be ineffective in alleviating the symptoms. The only long-term satisfying treatment option is the complete abstinence from cannabis consumption. Case Summary. In this case report we describe a 26-year-old male Caucasian long-term cannabis consumer who repeatedly presented in our emergency room with cyclic severe nausea and vomiting ceased by hot showers and resistant to all other treatments. The final diagnosis was not established until his third visit to the ER. Conclusion. CHS is an important differential diagnosis in patients who present with cyclic vomiting and abdominal pain with a history of long-term cannabis use. Recognition of this syndrome is important in order to avoid unnecessary clinical testing and to help the patients break the cycle of drug use.

Highlights

  • Cannabinoid Hyperemesis Syndrome (CHS) is a rare condition that includes cyclic severe vomiting in subjects who have been consuming large doses of cannabis for several years

  • In this case report we describe a 26-yearold male Caucasian long-term cannabis consumer who repeatedly presented in our emergency room with cyclic severe nausea and vomiting ceased by hot showers and resistant to all other treatments

  • CHS is an important differential diagnosis in patients who present with cyclic vomiting and abdominal pain with a history of long-term cannabis use

Read more

Summary

Introduction

Cannabis is a commonly used recreational drug, which contains the principal psychoactive component delta 9-tetrahydrocannabinol (THC). The Cannabinoid Hyperemesis Syndrome is rare and was first described in the year 2004 by Allen et al [5] and 2009 by Sontineni et al [6] who first tried to establish diagnostic criteria It has a delay in onset and is mostly observed in subjects who have been consuming large doses of cannabis over a period of several years. Diagnostic criteria were renewed after a case series of 98 patients of Mayo Clinic in 2012 and include severe cyclic nausea and vomiting, resolution with cannabis cessation, relief of symptoms with hot showers or baths, abdominal pain, and weekly use of marijuana as major criteria [8] (see “Proposed Clinical Criteria by Simonetto et al Mayo Clinic, 2012 [8]”). (i) Severe cyclic nausea and vomiting (ii) Resolution with cannabis cessation (iii) Relief of symptoms with hot showers or baths (iv) Abdominal pain: epigastric our periumbilical (v) Weekly use of marijuana. (i) Age less than 50 years (ii) Weight loss of >5 kg (iii) Morning predominance of symptoms (iv) Normal bowel habits (v) Negative laboratory and radiographic and endoscopic test results

Case Presentation
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call